$1.84
1.60% day before yesterday
Nasdaq, Jan 02, 10:16 pm CET

Pacific Biosciences of California, Inc. Stock price

$1.84
-0.48 20.69% 1M
+0.35 23.49% 6M
-0.03 1.60% YTD
+0.04 2.22% 1Y
-6.34 77.51% 3Y
-24.54 93.02% 5Y
-11.35 86.05% 10Y
-14.60 88.81% 20Y
Nasdaq, Closing price Fri, Jan 02 2026
-0.03 1.60%

Key metrics

Basic
Market capitalization
$555.5m
Enterprise Value
$902.0m
Net debt
$346.5m
Cash
$298.7m
Shares outstanding
301.9m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
3.6 | 3.5
EV/Sales
5.8 | 5.6
EV/FCF
negative
P/B
15.4
Financial Health
Equity Ratio
40.2%
Return on Equity
-61.2%
ROCE
-22.9%
ROIC
-36.0%
Debt/Equity
17.9
Financials (TTM | estimate)
Revenue
$154.6m | $160.9m
EBITDA
$-160.3m | $-163.0m
EBIT
$-169.3m | $-442.3m
Net Income
$-503.6m | $-489.5m
Free Cash Flow
$-131.3m
Growth (TTM | estimate)
Revenue
-10.7% | 4.5%
EBITDA
41.1% | 34.8%
EBIT
41.8% | -65.0%
Net Income
-27.7% | -58.0%
Free Cash Flow
45.2%
Margin (TTM | estimate)
Gross
31.0%
EBITDA
-103.7% | -101.3%
EBIT
-109.5%
Net
-325.8% | -304.2%
Free Cash Flow
-84.9%
More
EPS
$-1.7
FCF per Share
$-0.4
Short interest
12.9%
Employees
575
Rev per Employee
$270.0k
Show more

Is Pacific Biosciences of California, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,082 stocks worldwide.

Pacific Biosciences of California, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

17 Analysts have issued a Pacific Biosciences of California, Inc. forecast:

9x Buy
53%
8x Hold
47%

Analyst Opinions

17 Analysts have issued a Pacific Biosciences of California, Inc. forecast:

Buy
53%
Hold
47%

Financial data from Pacific Biosciences of California, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
155 155
11% 11%
100%
- Direct Costs 107 107
19% 19%
69%
48 48
16% 16%
31%
- Selling and Administrative Expenses 133 133
20% 20%
86%
- Research and Development Expense 96 96
34% 34%
62%
-160 -160
41% 41%
-104%
- Depreciation and Amortization 9.04 9.04
52% 52%
6%
EBIT (Operating Income) EBIT -169 -169
42% 42%
-110%
Net Profit -504 -504
28% 28%
-326%

In millions USD.

Don't miss a Thing! We will send you all news about Pacific Biosciences of California, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Pacific Biosciences of California, Inc. Stock News

Neutral
GlobeNewsWire
4 days ago
MENLO PARK, Calif., Dec. 30, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will be presenting at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026, at 10:30 AM PT (1:30 PM ET) in San Francisco, California.
Neutral
GlobeNewsWire
about one month ago
MENLO PARK, Calif., Nov. 28, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will participate in a fireside chat at Piper Sandler's 37th Annual Healthcare Conference on Wednesday, December 3, 2025, at 11:30 AM ET in New York, NY.
Neutral
Seeking Alpha
about 2 months ago
Pacific Biosciences of California, Inc. ( PACB ) Q3 2025 Earnings Call November 5, 2025 4:30 PM EST Company Participants Christian Henry - President, CEO & Director James Gibson - Chief Financial Officer Conference Call Participants Carrie Mendivil - Gilmartin Group LLC Kyle Mikson - Canaccord Genuity Corp., Research Division Madeline Mollman - Wolfe Research, LLC Thomas VonDerVellen - Guggenhe...
More Pacific Biosciences of California, Inc. News

Company Profile

Pacific Biosciences of California, Inc. engages in the development, manufacture and sale of an integrated platform for genetic analysis. Its products and services include PacBio sequel system, consumables, analytical software, and single molecule real-time (SMRT) compatible products. It operates through the following geographical segments: North America, Europe, and Asia Pacific. The company was founded by Stephen Turner and Joseph Vincent Bonventre on July 14, 2000 and is headquartered in Menlo Park, CA.

Head office United States
CEO Christian Henry
Employees 575
Founded 2000
Website www.pacb.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today